Liver Panel
Renal Panel
Lipid Panel
Cardiac Panel
Diabetes Panel
Special Protein Panel
Tumor Marker Panel
Pancreas Panel
Inorganic Panel
Inflammation Panel
TDM panel
Other Panel
| Abbr. | Description | Method | Package Size |
|---|---|---|---|
| PAMY | Pancreatic Amylase |
EPS-G7 MethodDouble reagent
|
|
| CA15-3 | Carbohydrate Antigen 15-3 |
Latex Immunoturbidimetric Method
|
|
| CYFRA 21-1 | Cytokeratin 19 Fragment Antigen 21-1 |
Latex Immunoturbidimetric Method
|
|
| COR | COR |
Homogeneous Enzyme Immunoassay Method
|
|
| Lp-PLA2 | Lipoprotein-associated Phospholipase A2 |
Continuous Monitoring Method
|
|
| sST2 | The soluble suppression of tumorigenicity-2 protein |
|
|
| HE4 | Human epididymis protein 4 |
Immunoturbidimetric Method
|
|
| CEA | Carcino-embryonic Antigen |
Latex Immunoturbidimetric Method
|
|
| IMA | Ischemia modified albumin |
Albumin-cobalt Binding
|
|
| FDP | Fibrin Degradation Products |
Latex Immunoturbidimetric Method
|
|
| ASO | Anti-streptolysin O |
Immunoturbidimetric Method
|
|
| Cre | Creatinine |
Sarcosine Oxidase Method
|
|
| SAA | Serum Amyloid A |
Latex Immunoturbidimetric MethodDouble reagent
|
|
| PCT | Procalcitonin |
Latex Immunoturbidimetric MethodDouble reagent
|
|
| CRP | C-reactive Protein |
Immunoturbidimetric MethodDouble reagent
|
|